Fulcrum Therapeutics, Inc. (FULC): Price and Financial Metrics Recent IPO
Fulcrum Therapeutics, Inc. (FULC) Recent IPO
Today's Latest Price: $11.97 USD
1.01 (9.22%)
Updated Dec 6 3:38pm
Add FULC to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
FULC Daily Price Range
FULC 52-Week Price Range
FULC Stock Price Chart More Charts
FULC Price/Volume Stats
| Current price | $11.97 |
| Prev. close | $10.96 |
| Day low | $10.45 |
| Day high | $12.47 |
| 50-day MA | $7.88 |
| 200-day MA | $0.00 |
| 52-week high | $15.94 |
| 52-week low | $4.37 |
| Volume | 40,306 |
| Avg. volume | 70,640 |
| Dividend yield | N/A |
| Market Cap | 279.39M |
Fulcrum Therapeutics, Inc. (FULC) Company Bio
Fulcrum Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies. Its product candidate includes Losmapimod and FTX-HbF. The company was founded by Michael R. Green, Danny Reinberg, Rudolf Jaenisch, Jeannie T. Lee, and Bradley E. Bernstein on August 18, 2015 and is headquartered in Cambridge, MA.
Top Stories View All
3 Investment Lessons Learned in 2019
Does OrganiGram’s (OGI) New Equity Program Mean it’s Time to Buy the Stock?
Why I’m Bearish On Disney (DIS) in the Short-term
Best & Worst Performing Stock Industries for December 5, 2019
Best & Worst Performing Small Cap Stocks for December 5, 2019
View All Top Stories
Loading social stream, please wait...